StockData
NeoGenomics Inc logo

NeoGenomics Inc (NEO) stock

NEONasdaqServices-Testing LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 11/3023% below fair value
$15.25−0.16 (-1.04%)

Close on Nov 17, 2026Market cap $1.97BP/E –Yield –

NeoGenomics r&d expenses

Research and development expenses are spending on new products and technology.

NeoGenomics's R&D Expenses for the twelve months ending Sep 30, 2026 was $39.33M, up 9.7% year over year. For fiscal 2025 it was $37.08M, up 19.0% from the year before. Over ten years it grew 24.3% a year on average. The highest annual figure on record is $37.08M in fiscal 2025.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$37.08M+19.0%
FY2024Dec 31, 2024$31.16M+14.1%
FY2023Dec 31, 2023$27.31M-9.9%
FY2022Dec 31, 2022$30.33M+38.6%
FY2021Dec 31, 2021$21.87M+165.8%
FY2020Dec 31, 2020$8.23M-3.0%
FY2019Dec 31, 2019$8.49M+182.8%
FY2018Dec 31, 2018$3.00M-17.5%
FY2017Dec 31, 2017$3.64M-21.8%
FY2016Dec 31, 2016$4.65M+10.7%
FY2015Dec 31, 2015$4.20M+56.1%
FY2014Dec 31, 2014$2.69M+10.2%
FY2013Dec 31, 2013$2.44M+7.0%
FY2012Dec 31, 2012$2.28M+320.1%
FY2011Dec 31, 2011$543.00K–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$9.86M+13.4%
Q2 FY2026Jun 30, 2026$10.76M+19.3%
Q1 FY2026Mar 31, 2026$9.53M-6.4%
Q4 FY2025Dec 31, 2025$9.18M+15.2%
Q3 FY2025Sep 30, 2025$8.69M+13.1%
Q2 FY2025Jun 30, 2025$9.02M+14.4%
Q1 FY2025Mar 31, 2025$10.18M+33.6%
Q4 FY2024Dec 31, 2024$7.97M+11.8%
Q3 FY2024Sep 30, 2024$7.68M+45.4%
Q2 FY2024Jun 30, 2024$7.89M+5.1%
Q1 FY2024Mar 31, 2024$7.62M+3.0%
Q4 FY2023Dec 31, 2023$7.13M+6.8%
Q3 FY2023Sep 30, 2023$5.29M-27.7%
Q2 FY2023Jun 30, 2023$7.50M-13.0%
Q1 FY2023Mar 31, 2023$7.40M-4.1%
Q4 FY2022Dec 31, 2022$6.68M-21.6%
Q3 FY2022Sep 30, 2022$7.31M-1.3%
Q2 FY2022Jun 30, 2022$8.63M+146.8%
Q1 FY2022Mar 31, 2022$7.71M+214.0%
Q4 FY2021Dec 31, 2021$8.51M+305.4%
Q3 FY2021Sep 30, 2021$7.41M+277.2%
Q2 FY2021Jun 30, 2021$3.50M+66.0%
Q1 FY2021Mar 31, 2021$2.46M+19.2%
Q4 FY2020Dec 31, 2020$2.10M+1.0%
Q3 FY2020Sep 30, 2020$1.96M-24.8%
Q2 FY2020Jun 30, 2020$2.11M-18.6%
Q1 FY2020Mar 31, 2020$2.06M+70.4%
Q4 FY2019Dec 31, 2019$2.08M+295.4%
Q3 FY2019Sep 30, 2019$2.61M+485.4%
Q2 FY2019Jun 30, 2019$2.59M+141.1%
Q1 FY2019Mar 31, 2019$1.21M+26.5%
Q4 FY2018Dec 31, 2018$526.00K-5.4%
Q3 FY2018Sep 30, 2018$446.00K-64.9%
Q2 FY2018Jun 30, 2018$1.07M+13.3%
Q1 FY2018Mar 31, 2018$956.00K+10.9%
Q4 FY2017Dec 31, 2017$556.00K-40.2%
Q3 FY2017Sep 30, 2017$1.27M–
Q2 FY2017Jun 30, 2017$947.00K–
Q1 FY2017Mar 31, 2017$862.00K–
Q4 FY2016Dec 31, 2016$930.00K–

More NeoGenomics figures

See a number that looks wrong?